| Financial Year |
March 31 2023 |
| Monetary Funds |
3,351,726,116.39 |
| Held-for-trading Financial Assets |
78,430,575.90 |
| Notes Receivable |
1,830,192.83 |
| Accounts Receivable |
5,019,833,736.05 |
| Advances to Suppliers |
39,778,288.34 |
| Other Receivables |
141,733,258.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,127,242,095.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
116,084,894.44 |
| Total Current Assets |
13,876,236,763.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
615,628,726.76 |
| Investment Properties |
158,041,424.39 |
| Fixed Assetes |
7,858,187,029.25 |
| Under-construction Projects |
1,635,206,940.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
392,654,636.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
229,412,362.12 |
| Other Non-Current Assets |
20,958,482.98 |
| Sub-Total of Non-Current Assets |
10,976,606,179.69 |
| Total Assets |
24,852,842,942.97 |
| Short-Term Loans |
1,421,997,092.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
373,392,584.10 |
| Accounts Payable |
2,938,668,733.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
298,486,660.49 |
| Taxes Payable |
42,212,047.49 |
| Interest Payable |
-- |
| Dividend Payable |
19,017,966.69 |
| Other payables |
351,118,498.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,479,794,687.92 |
| Other Current Liabilities |
819,237.51 |
| Sub-Total of Current Liabilities |
6,928,111,801.71 |
| Long-term Loans |
891,044,575.28 |
| Bonds Payable |
800,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
124,552,263.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,267,228,222.81 |
| Total Liabilities |
9,195,340,024.52 |
| Paid-In Capital(Or Share Stock) |
2,338,040,957.00 |
| Capital Surplus |
4,426,160,350.73 |
| Surplus Reserve |
1,510,420,032.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,602,455,136.70 |
| Minority Stockholder's Interest |
1,774,551,787.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,882,951,131.45 |
| Owner's Equity（Stockholder's Equity） |
15,657,502,918.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,852,842,942.97 |
